Shopping Cart
Remove All
Your shopping cart is currently empty
TAK-779 (Takeda 779) is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $38 | In Stock | In Stock | |
| 5 mg | $89 | In Stock | In Stock | |
| 10 mg | $139 | In Stock | In Stock | |
| 25 mg | $253 | In Stock | In Stock | |
| 50 mg | $428 | In Stock | In Stock | |
| 100 mg | $639 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $97 | In Stock | In Stock |
| Description | TAK-779 (Takeda 779) is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3). |
| Targets&IC50 | R5 HIV-1 (KK):20.8 nM (EC90, in PBMCs), MIP-1α-CCR5:1 nM (in CHO/CCR5 cells), R5 HIV-1 (CTV):3.5 nM (EC50 , in PBMCs), RANTES-CCR5:1.4 nM (in CHO/CCR5 cells), R5 HIV-1 (Ba-L):5.7 nM (EC90, in MAGI-CCR5 cells), MCP-1-CCR2b:27 nM (in CHO/CCR5 cells), CXCR3 (mouse):369 nM (in PBMCs), R5 HIV-1 (Ba-L):1.2 nM (EC50, in MAGI-CCR5 cells), R5 HIV-1 (Ba-L):12.8 nM (EC90, in PBMCs), R5 HIV-1 (CTV):27 nM (EC90, in PBMCs), R5 HIV-1 (Ba-L):3.7 nM (EC50, in PBMCs), R5 HIV-1 (HHA):7.5 nM (EC90, in PBMCs), MIP-1β-CCR5:1 nM (in CHO/CCR5 cells), R5 HIV-1 (HHA):3.2 nM (EC50 , in PBMCs), R5 HIV-1 (KK):1.6 nM (EC50, in PBMCs) |
| In vitro | TAK-779 (250 mg/animal per day) inhibits ovalbumin-induced increases in CCR5, CXCR3, IFN-γ, and TNF-α expression in mouse lung, as well as the number of total cells, lymphocytes, and eosinophils in bronchoalveolar lavage fluid (BALF), in a mouse model of asthma[1]. |
| In vivo | TAK-779 increases intestinal allograft survival in a rat model of small intestine transplantation when administered at a dose of 10 mg/kg per day[2]. |
| Synonyms | Takeda 779 |
| Molecular Weight | 531.13 |
| Formula | C33H39ClN2O2 |
| Cas No. | 229005-80-5 |
| Smiles | [Cl-].Cc1ccc(cc1)-c1ccc2CCCC(=Cc2c1)C(=O)Nc1ccc(C[N+](C)(C)C2CCOCC2)cc1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | H2O: 16.66 mg/mL (31.37 mM), Sonication is recommended. DMSO: 25 mg/mL (47.07 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.77 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
H2O/DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.